Kendall Capital Management Innoviva, Inc. Transaction History
Kendall Capital Management
- $331 Million
- Q4 2024
A detailed history of Kendall Capital Management transactions in Innoviva, Inc. stock. As of the latest transaction made, Kendall Capital Management holds 33,615 shares of INVA stock, worth $613,809. This represents 0.18% of its overall portfolio holdings.
Number of Shares
33,615
Previous 34,590
2.82%
Holding current value
$613,809
Previous $667,000
12.59%
% of portfolio
0.18%
Previous 0.21%
Shares
8 transactions
Others Institutions Holding INVA
# of Institutions
232Shares Held
79.1MCall Options Held
37.6KPut Options Held
300-
Black Rock Inc. New York, NY9.63MShares$176 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$133 Million34.93% of portfolio
-
Franklin Resources Inc San Mateo, CA6.75MShares$123 Million0.04% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$114 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.23MShares$114 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.27B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...